Please assess the completion status of the following clinical trial:

Trial Title: Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Participated in study 580299/001 and received all three doses of vaccine/placebo.~* Written informed consent obtained from the subject prior to enrollment~Exclusion Criteria:~* Decoding of the subject's treatment allocation to either the subject or the investigator in study 580299/001.

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 30 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).